User profiles for Thomas Perkmann
Thomas PerkmannMedical University of Vienna, Department of Laboratory Medicine Verified email at meduniwien.ac.at Cited by 6852 |
[HTML][HTML] Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury
…, GG Neely, R Yaghubian-Malhami, T Perkmann… - Cell, 2008 - cell.com
Multiple lung pathogens such as chemical agents, H5N1 avian flu, or SARS cause high
lethality due to acute respiratory distress syndrome. Here we report that Toll-like receptor 4 (TLR4…
lethality due to acute respiratory distress syndrome. Here we report that Toll-like receptor 4 (TLR4…
Anti-spike protein assays to determine SARS-CoV-2 antibody levels: a head-to-head comparison of five quantitative assays
T Perkmann, N Perkmann-Nagele, T Koller… - Microbiology …, 2021 - Am Soc Microbiol
Reliable quantification of the antibody response to severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) is highly relevant, eg, for identifying possible vaccine failure and …
coronavirus 2 (SARS-CoV-2) is highly relevant, eg, for identifying possible vaccine failure and …
Side-by-side comparison of three fully automated SARS-CoV-2 antibody assays with a focus on specificity
T Perkmann, N Perkmann-Nagele, MK Breyer… - Clinical …, 2020 - academic.oup.com
Background In the context of the COVID-19 pandemic, numerous new serological test systems
for the detection of anti-SARS-CoV-2 antibodies rapidly have become available. However…
for the detection of anti-SARS-CoV-2 antibodies rapidly have become available. However…
[HTML][HTML] Oxidation-specific epitopes are dominant targets of innate natural antibodies in mice and humans
…, PX Shaw, J Choi, T Perkmann… - The Journal of …, 2009 - Am Soc Clin Investig
Atherosclerosis is a chronic inflammatory disease characterized by the accumulation of
oxidized lipoproteins and apoptotic cells. Adaptive immune responses to various oxidation-…
oxidized lipoproteins and apoptotic cells. Adaptive immune responses to various oxidation-…
SARS-CoV-2 vaccination in rituximab-treated patients: B cells promote humoral immune responses in the presence of T-cell-mediated immunity
…, H Radner, D Sieghart, P Hofer, T Perkmann… - Annals of the …, 2021 - ard.bmj.com
Objectives Evidence suggests that B cell-depleting therapy with rituximab (RTX) affects
humoral immune response after vaccination. It remains unclear whether RTX-treated patients …
humoral immune response after vaccination. It remains unclear whether RTX-treated patients …
Mean platelet volume may represent a predictive parameter for overall vascular mortality and ischemic heart disease
G Slavka, T Perkmann, H Haslacher… - … , and vascular biology, 2011 - Am Heart Assoc
Objective— An increased mean platelet volume (MPV), as an indicator of larger, more
reactive platelets resulting from an increased platelet turnover, may represent a risk factor for …
reactive platelets resulting from an increased platelet turnover, may represent a risk factor for …
SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response
MM Bonelli, D Mrak, T Perkmann… - Annals of the …, 2021 - ard.bmj.com
1 Rimar D, Butbul Aviel Y, Gefen A, et al. Autologous hematological stem cell transplantation
for systemic sclerosis in Israel. Isr Med Assoc J 2020; 22: 104–10. 2 Kowal-Bielecka O, …
for systemic sclerosis in Israel. Isr Med Assoc J 2020; 22: 104–10. 2 Kowal-Bielecka O, …
[PDF][PDF] Coagulation parameters and major bleeding in critically ill patients with cirrhosis
…, P Schellongowski, G Heinz, T Perkmann… - …, 2016 - Wiley Online Library
Disturbances of coagulation and hemostasis are common in patients with liver cirrhosis. The
typical laboratory pattern mimics disseminated intravascular coagulation (DIC). The aim of …
typical laboratory pattern mimics disseminated intravascular coagulation (DIC). The aim of …
A randomized clinical trial of anti–IL-6 antibody clazakizumab in late antibody-mediated kidney transplant rejection
…, G Gelbenegger, T Perkmann… - Journal of the …, 2021 - journals.lww.com
Background Late antibody-mediated rejection (ABMR) is a leading cause of transplant
failure. Blocking IL-6 has been proposed as a promising therapeutic strategy. Methods We …
failure. Blocking IL-6 has been proposed as a promising therapeutic strategy. Methods We …
Vesicles generated during storage of red cells are rich in the lipid raft marker stomatin
…, M Luten, H Isobe, V Pastushenko, T Perkmann… - …, 2008 - Wiley Online Library
BACKGROUND: The release of vesicles by red blood cells (RBCs) occurs in vivo and in vitro
under various conditions. Vesiculation also takes place during RBC storage and results in …
under various conditions. Vesiculation also takes place during RBC storage and results in …